Basics |
Company: |
Cue Biopharma, Inc. |
IPO Date: |
January 2, 2018 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$63.98M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.29 | 3.73%
|
Avg Daily Range (30 D): |
$0.07 | 5.64%
|
Avg Daily Range (90 D): |
$0.08 | 7.29%
|
Institutional Daily Volume |
Avg Daily Volume: |
.23M |
Avg Daily Volume (30 D): |
.31M |
Avg Daily Volume (90 D): |
.55M |
Trade Size |
Avg Trade Size (Sh.): |
119 |
Avg Trade Size (Sh.) (30 D): |
226 |
Avg Trade Size (Sh.) (90 D): |
289 |
Institutional Trades |
Total Inst.Trades: |
182 |
Avg Inst. Trade: |
$2.17M |
Avg Inst. Trade (30 D): |
$3.81M |
Avg Inst. Trade (90 D): |
$3.81M |
Avg Inst. Trade Volume: |
.22M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.2M |
Avg Closing Trade (30 D): |
$3.81M |
Avg Closing Trade (90 D): |
$3.81M |
Avg Closing Volume: |
236.3K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-.91
|
$-.17
|
$-.2
|
Diluted EPS
|
$-.91
|
$-.17
|
$-.2
|
Revenue
|
$ 9.53M
|
$ 3.34M
|
$ 2.66M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -44.61M
|
$ -8.66M
|
$ -10.17M
|
Operating Income / Loss
|
$ -45.7M
|
$ -8.82M
|
$ -10.38M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -22.27M
|
$ 2.39M
|
$ -11M
|
PE Ratio
|
|
|
|
|